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Abstract 
Nucleic acid recognition is often mediated by α-helices or disordered regions that fold into α-
helix upon binding. A peptide bearing the DNA recognition helix of HPV16 E2 displays type II 
polyproline (PII) structure as judged by pH, temperature, and solvent effects on the CD spectra. 
NMR experiments indicate that the canonical α-helix is stabilized at the N-terminus, while the 
PII forms at the C-terminus half of the peptide. Reexamination of the dihedral angles of the DNA 
binding helix in the crystal structure and analysis of the NMR chemical shift indexes confirm 
that the N-terminus half is a canonical α-helix, while the C-terminal half adopts a 310 helix 
structure. These regions precisely match two locally driven folding nucleii, which partake in the 
native hydrophobic core and modulate a conformational switch in the DNA binding helix. The 
peptide shows only weak and unspecific residual DNA binding, 10
4
-fold lower affinity and 500-
fold lower discrimination capacity compared to the domain. Thus, the precise side chain 
conformation required for modulated and tight physiological binding by HPV E2 is largely 





DNA binding proteins often recognize their target sequences and exert their functions via α-
helices 
1,2
. These helices may be held into a fixed structural arrangement in the unbound state by 
the tertiary and quaternary structure of the domain 
1,2
 or, alternatively, fold upon binding 
3-5
. The 
observation of helices that fold upon binding 
6-9
, hints that DNA-binding helices within globular 
domains may behave similarly in isolation as long as they have helical propensity. 
The C-terminal domain of the E2 protein from human papillomavirus type 16 (E2C) is a well 
characterized model for α-helix-mediated DNA sequence recognition 10. Binding of E2C to its 
target DNA regulates the expression and replication of the papillomavirus genome 
10
, and the 
differences between E2C domains from high- and low-risk human papillomavirus types may lead 
to differenctial effects on its described multiple funcions in HPV’s life cycle 
11,12
. The E2C 
sequence folds into a homodimeric eight-stranded barrel composed of 4 strands from each 
symmetric monomer, with two helices per monomer packing against the outside of the barrel 
10,13,14
. The topology can be described by two repetitions of  β-α-β secondary structure elements. 
This topology is unusual, being shared only by the DNA binding domain of the Epstein Barr 
nuclear antigen 1 
15
, which presents neither homology nor DNA binding specificity or 
phylogenetic relationship with E2C.  
The highly conserved E2C helix-1 is the main DNA recognition element of the domain (Figure 
1) 
16-19
. Site-directed mutagenesis shows that the DNA binding helix accounts for most of the 
free energy of binding 
20
 and stabilizes the transition state for the two-state binding route 
21
. The 
DNA binding helix belongs to the first  β-α-β element and spans residues 293 to 305 according 
to the numbering of HPV16 E2C. Although this rough classification is correct in overall terms, a 









 and HPV16 
13,14
 reveals that the region of the DNA binding helix 
can be reclassified as a mixed α- and 310-helix (Figure 1). The length of the α-helix varies from 
10 residues (HPV6) to 14 residues (HPV18 monomer A and BPV1). It is even variable between 
the two monomers of HPV18. Conserved residues contacting directly the DNA bases (N294, 
K297, C298, Y301 and R302) 
11
 are all in the first 10 residues from the N-cap, which is the 
minimum length for the α-helix. There are also non-specific contacts between N294, T295, 
K297, R300, Y301 and R302 and the DNA backbone 
21
. A second region involving the C-
 4 
terminal half of the DNA binding helix, variable in length but present in all strains, contains 310 
helix as suggested by molecular simulations 
26
. This stretch shows a series of positively charged 




The E2C DNA binding helix is anchored to the rest of the domain by three residues forming 
extensive hydrophobic interactions with the outer face of the β-barrel, L296, L299 and F303 
10,13,14
. The DNA binding helix presents a well defined conformation in all crystal structures 
available to date 
13,14,19,22-25
. However, it was noticed that amide hydrogens of the HPV31 E2C 
DNA binding helix exchange with solvent unexpectedly fast, suggesting that the helix is 
dynamically fluctuating 
22
. On the other hand, the HPV16 E2C DNA binding helix shows a 
deviation from a canonical α-helix in the C-terminus 13,14. Molecular dynamics studies suggest 
that the HPV16 protein presents a flexible DNA binding helix and a rigid β-barrel, whereas the 
BPV1 protein shows the opposite conformational behavior 
26
. More recently, experimental 
evidence for the backbone mobility of some residues belonging to the HPV16 E2C DNA binding 
helix was presented 
27
. This flexible region undergoes subtle changes when E2C binds its target 
DNA 
14,27
 and modulates binding of anti-E2C antibodies 
28
. 
Upon addition of urea or guanidinium chloride, E2C unfolds in a two-state manner without 
populated intermediates 
18,29
. There is residual structure in the unfolded state in the region of the 
DNA binding helix (Figure 1) 
30
, which may play a role in the initiation of folding 
31,32
. E2C can 
also form amyloid fibrils under mild solvent conditions 
33
. Unfolding of the DNA binding helix 
is necessary for this transition to take place, suggesting that its unusual dynamic properties may 
help triggering an amyloid route in a quasi-spontaneous equilibrium 
33,34
. 
The E2C DNA binding helix seems to be the key to folding and function of the HPV16 E2 
protein, the master regulator of a high-risk papillomavirus type 
35
. In this work we investigate the 
conformational preferences and DNA binding capacity of the isolated DNA binding helix using a 
synthetic 19mer peptide. We then compare these properties with those of the DNA binding site 
in the context of the whole domain and found a strong correlation with folding nuclei 
30
 and a 
conformational switch. We discuss the implications for α-helix-nucleic acid binding in general. 
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RESULTS 
Polyproline type II and α-helix conformations in α1-E2C from circular dichroism. 
The peptide studied in this work (α1-E2C) corresponds to the DNA binding helix of the HPV16 
E2C domain, plus flanking residues (Figure 1). We have used far-UV circular dichroism (CD) to 
determine the conformational state of the peptide in solution. In 10 mM sodium phosphate, pH 
7.0 at 25 °C, α1-E2C shows a spectrum of an apparently disordered conformation, in particular 
compared to that of the E2C domain (Figure 2A). Careful examination of the spectra shows 
negative bands at 200 and 228 nm and a positive band at 218 nm, compatible with a mixture of 
random coil and polyproline type II (PII) conformations 
36
. The ratio of the molar ellipticities at 
222 and 208 nm is approximately 0.4, far from the value of 1 expected for a stable α-helix and 
further supporting the presence of PII conformation 
37
. 
PII conformations are sensitive to temperature, with higher temperatures decreasing the intensity 
of the peak at 218 nm 
38,39
. This is indeed evident from the temperature dependence of the CD 
spectrum of α1-E2C (Figure 2A). The characteristic broad positive band at 218 nm can be 
clearly observed in the difference spectra between 5 and 85 °C. The presence of an isodichroic 
point in the temperature transition suggests a two-state equilibrium between PII and a more 
unstructured state. The minimum at 199 nm at low temperature is shifted to 202 nm at the 
highest temperature, further supporting the presence of temperature-sensitive PII structure. 
PII conformations can be stabilized by addition of denaturants such as guanidinium chloride 
(GdmCl) 
39,40
. Addition of up to 6M GdmCl induces the formation of PII structure in α1-E2C 
(Figure 2B), as evidenced by the increase in the positive band around 218 nm. The inset shows a 
fit of the observed molar ellipticity at 5 °C and 218 nm to a two-state coil-PII model (see 
materials and methods, 
39
). The calculated change in free energy for the coil-PII equilibrium in 0 
M GdmCl is 1.3 ± 0.3 kcal/mol, which corresponds to 8.6 ± 4.5 % of PII. A similar transition 
was observed at 25 °C (change in free energy 2.0 ± 0.6 kcal/mol) or if urea is employed instead 
of GdmCl (data not shown). Although the two-state model is most likely only a crude 
approximation for the conformational equilibria of  the peptide, these results clearly confirm that 
for α1-E2C in solution there is an equilibrium between coil and PII conformations. 
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The ellipticity of α1-E2C between pH 5 and 9 shows a defined transition around pH 7 (Figure 
2C and inset). There is an increase in PII conformation at higher pH values, as deduced from the 
increase of the ellipticity at 200 nm and the shift in the minimum from 200 to 202 nm. We assign 
this transition to histidine 306, the only ionizable group of the peptide in this range (Figure 1). 
The central residues of α1-E2C are in an α-helical conformation in the full-length E2C domain. 
We used 1,1,1-trifluoroethanol (TFE) to detect and quantify the residual helical structure present 
in the peptide 
41,42
. The addition of increasing concentrations of TFE to α1-E2C induces the 
appearance of two negative bands at 222 and 208 nm in the CD spectrum, typical of an α-helix 
41,42
 (Figure 2D). The inset shows a fit of the observed molar ellipticity at 222 nm to a two-state 
coil-helix model (see materials and methods). The approximation of the helix-coil equilibrium to 
a two-state model is supported by the presence of an isodichroic point at around 203 nm and 
aims only at an estimation of the helical content in the absence of cosolvent. The fitted change in 
free energy for the coil-helix equilibrium in the absence of TFE is 1.7 ± 0.2 kcal/mol, which 
corresponds to 5.2 ± 1.7 % of helix. The molar ellipticity at high concentrations of TFE is –
17830 deg⋅cm2/dmol. When compared to the standard molar ellipticity of a residue in a helical 
conformation 
43
 (see methods), our result corresponds to 10 of the 19 amino acids of the peptide 
(53%) being on average in α-helix structure. This figure is in excellent agreement with the 11 
residues of canonical helix in full-length E2C (Figure 1) 
14,19
. 
Determination of α-helix and PII structures in α1-E2C by NMR 
We investigated the solution structure of α1-E2C by NMR spectroscopy, which provides 
information about the conformation of individual residues in the sequence. Similar to CD 
measurements, we analyzed the conformation of the peptide in aqueous solution, in a water-TFE 





H]-HMQC spectrum for α1-E2C in the three solvent conditions (see also Tables I, II 
and III of supplementary material for chemical shift assignments of α1-E2C). The analysis was 
carried out using coupling constants and chemical shifts in addition to the usual NOE 
observations, to minimize biased conclusions that can be obtained in highly flexible systems. 
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The analysis of the secondary chemical shifts allows determining the elements of secondary 
structure stabilized in the peptide in the different environments here studied. Figure 4A shows 
the chemical shift index (CSI) 
44
 of the Hα, Cα, and Cβ resonances of the α1-E2C peptide in the 
aqueous buffer and in the water-TFE and water-urea solutions. CSI values of -1, +1 and -1 for 
Hα, Cα, and Cβ, respectively, are indicative of α-helical conformations (depicted as upward red 
arrows in the figure), while the opposite values are observed for β-strands (downward blue 
arrows in the figure). In contrast, 0 indexes (gray bars in Figure 4) suggest that no secondary 
chemical shift is observed for the given nucleus. 
In the TFE solution the α-helical conformation spans from A293 to H306 as evidenced from the 
CSI analysis (Figure 4A). This result is consistent with the NOESY pattern, where α-helix 
characteristic crosspeaks are observed for this region (data not shown). 
1
JCαHα values larger than 




JHNHα smaller than random coil values, in general smaller than 5 Hz, 
are typical for α-helices 46. The values of 1JCαHα and 3JHNHα coupling constants for this tract are 
indeed indicative of an α-helix (Figure 4B, black, and Tables IV and V of supplementary 
material).  
In order to investigate regions involving PII conformation in α1-E2C, we studied its behavior in 
a solution containing 8 M urea. As expected for high denaturant concentrations, the chemical 
shifts appear mainly clustered according to amino acid type (Figure 3). Correspondingly, most of 
the CSI observed are 0, except for the C-terminal region of the peptide (Figure 4A). This region 
displays some Cα, and Cβ indexes compatible with a β-strand conformation, while the Hα 
indexes are zero. Overall, from the CSI analysis, in the urea-water mixture the peptide seems to 
adopt a disordered structure with the stabilization of an extended conformation in the C-terminal 
region. The PII is an extended left-handed helix, often lacking characteristic proton or carbon 
chemical shift deviations from random coil values as found in α-helix and β-sheet conformations 
47,48
. This absence of chemical shift dispersion leads to a strong overlap of signals in the NOESY 
spectrum and precludes an accurate determination of PII structure solely from chemical shifts 
and from the pattern of NOESY crosspeaks. As a consequence, PII is often misclassified as 
random coil conformation by NMR techniques 
48,49
. Although the C-terminal region of the 
peptide displays some CSI coherent with a β-strand conformation, inspection of the 1JCαHα values 
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shows values larger than those observed in a random coil conformation for this tract (Figure 4B, 
red), while β-strands display the 1JCαHα smaller than random coil 45. Likewise, the difference 
between measured 
1
JCαHα and random coil values characteristic of PII helices is reported to be 
larger than 1.1 Hz 
48
. In the case of α1-E2C in urea, 1JCαHα larger than random coil values are 
observed systematically for residues from L299 to K305 (Figure 4B and Table IV of 
supplementary material). The 
1
JCαHα values of these residues are larger in the urea solution at 
5°C than at 25°C (see Table IV of supplementary material) 
38
. Since the large 
1
JCαHα values 
increase at 5°C and are incompatible with a β-strand, we conclude that residues L299 to K305 
adopt PII conformation. The location of PII explains the influence of the protonation state of 
nearby histidine 306 on the coil-PII equilibrium deduced from the pH titration of α1-E2C 
(Figure 2C).  
Two distinct structural regions for α1-E2C in aqueous solution. 
From CD experiments, we know that both PII and helix conformations are partially stabilized in 
aqueous solution (Figure 2). Complementing NMR experiments can assign conformations to 
specific residues of the peptide. From A293 to L299, the crosspeak pattern in the NOESY 
spectrum and the CSI show a tendency of the peptide to adopt α-helical structure (Figure 4A). 
This tendency is weaker in water than in TFE, as judged from the magnitude of the chemical 
shifts and the very low intensity of the NH-NH (i, i+1) crosspeaks characteristic of α-helices 
(data not shown). Cβ indexes are 0 for this region in water, in contrast to -1 observed in TFE. In 
addition, the mean difference with random coil values is -0.18 and 0.9 ppm for Hα and Cα nuclei, 
respectively, for residues 293-299 in water, versus -0.25 and 3.4 ppm for the same nuclei in the 
TFE solution. From residue R300 to the C-terminal end of the peptide, the chemical shifts are 
more similar to random coil values. Interestingly, these residues have 
1
JCαHα constants larger 
than those observed for random coil conformation (Figure 4B, blue and Table IV of 
supplementary material). The 
1
JCαHα coupling constants for this tract are even larger in the 
presence of urea (Figure 4B), a clear evidence that the PII conformation spans these residues. 
In aqueous solution, α1-E2C shows a dynamic behavior, displaying a conformational 
equilibrium between disordered conformations and a nascent PII and disordered conformations 
and an α-helix structure in two well-differentiated regions. The PII region that includes R300 to 
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K305 corresponds very well with the PII detected in the presence of urea. The α-helix, however, 
only spans from A293 to L299 compared to the 293-305 region detected in the presence of TFE. 
Conformation of the DNA binding helix in α1-E2C versus in the context the full-length 
E2C domain 
We examined whether the conformational space explored by α1-E2C resembles that of the DNA 
binding helix in the context of the full-length domain. The determined three dimensional 
structure of HPV16 E2C defined residues 292-305 as the DNA binding helix 
19
, matching the 
region of the peptide that forms an α-helix in the presence of TFE. In order to correlate the 
results in solution presented here, together with NMR data indicating non-canonical structures in 
solution, we carefully reexamined the DNA binding helix of the crystal structure. The observed 
dihedral angles are compatible with a α-helix only for the tract 293-303, whereas the region 304-
309 displays characteristics of 310 helix (Figure 1). Figure 4C shows the CSI for Hα, Cα, Cβ and 
CO nuclei for residues 289-307 in the protein 
38
. Chemical shifts, the NOE pattern (not shown), 
and the 
3
JHNH (Table V supplementary material) observed for this region of the protein are 
compatible with a very stable α-helix limited to the region A293-R302 13. Thus, in the N-
terminal region, the tertiary structure of the domain can consolidate the local conformational 
tendencies of α1-E2C. The DNA binding helix kinks at residue F303, which presents unusual 
chemical shift values, and residues 303-305 show deviations from canonical α-helix 13,14,26 
(Figure 4C). In the C-terminal region, the tertiary contacts do not completely override the mixed 
helix/PII local tendencies of the sequence, leading to a distorted and kinked DNA binding helix 
after F303. This confirms the reclassification of the DNA binding helix of the crystal structure as 
pure α-helix for residues 293-303, and 310 helix for residues 304-309. 
Conformational plasticity of the DNA binding helix in the context of the full-length E2C 
domain  





nuclei of the imidazolic ring for all histidines were already presented 
13


















By following their chemical shift as a function of pH we could estimate the apparent pKa for 
each histidine. We have further explored the conformational plasticity of the C-terminal region 
of the DNA binding helix in full-length E2C by measuring the influence of H306 protonation on 
its conformation. The observed pKa for H306 following the chemical shift of H
ε1
 is 5.65 ± 0.05 
(Figure 5A) (a complete structural and dynamic analysis of the pKa of all histidine side chains 
will be published elsewhere). The resulting pKa is about 0.6 units lower than that expected for a 
solvent exposed histidine, indicating that the protein tertiary structure stabilizes the neutral form 
of H306. The observed chemical shift for the two nitrogens in the non-protonated state (211.4 




, respectively), indicate that this histidine exist as a mixture of 
~6:4 of the N
ε2
-H and the N
δ1
-H tautomers. Taking into account that for a solvent exposed 
histidine the expected population of the two tautomers is 4:1 
50
, the interaction of H306 with both 
the DNA binding helix and the hydrophobic core of the monomer stabilizes the N
δ1
-H tautomer. 
The interconversion between the two tautomers is fast, leading to a rapid movement of the 
hydrogen between the two nitrogens. 
In order to estimate the influence of the protonation of H306 on the chemical shift of amide 




N HSQC were recorded in the same range of pH (5.0-9.0). In this way, 
it was possible to detect those residues that titrate with the same apparent pKa as H306 and the 
associated differences in 
15
N chemical shift between the conformers with protonated and non 
protonated H306 (see methods). As an example, Figure 5B shows the titration curve for the 
amide nitrogen of F303. It displays an apparent pKa of 5.75 ± 0.08, in excellent agreement with 
the value found following the H
ε1
 signal of H306. Overall, eleven residues were found to be 
perturbed by H306 protonation (Figure 5C). These residues include the C-terminus of the helix 
(R300-R302), F303, the entire 310 helix (K304-L309) and three residues close in space (T316, 
Y335 and Q347).  
Mutation of “hinge” residue F303 to leucine stabilizes the E2C domain but decreases the 
affinity for its target DNA 
The atypical C-terminal region of the E2C DNA binding helix is anchored to the tertiary 
structure of the domain by phenylalanine 303 
13
. E2C F303 shows unusual values for the Hα and 
Cα chemical shifts (Figure 4) and is strongly perturbed by titration of residue H306 (Figure 5). 
 11 
We hypothesized that F303 is crucial for fixing the highly plastic 300-307 sequence in a 
biologically active conformation. We tested this hypothesis by mutating F303 to leucine and 
measuring the changes on specific DNA binding and E2C stability against irreversible 
denaturation. 
We previously reported that 17 mutations of residues forming direct contacts with the DNA have 
small effects on the stability of E2C, decreasing the temperature denaturation mid-temperature 
(Tm) by 0.6 ± 1.6 °C 20. In contrast, the F303L mutant is clearly more stable than wild-type E2C, 
having a higher Tm (Figure 6A). A fit of the data to a one-step irreversible denaturation model for 
a transition between a native dimer and an irreversibly denatured monomer 
51,52
 yields a Tm of 
50.5 ± 0.2 °C (EA 29.9 ± 0.9 kcal/mol) for the wild-type protein and 57.5 ± 0.2 °C (EA 30.3 ± 0.8 
kcal/mol) for the F303L mutant. A possible explanation is that a leucine at position 303 of E2C 
is better at locking the 300-307 sequence in a folded conformation than phenylalanine. 
We have also measured binding of F303L E2C to a cognate target site-35 from the HPV16 
genome (Figure 6B). The dissociation constant for this variant is 11.4±0.1 nM, as compared to 
1.2±0.1 nM in the case of the wild type domain 
20
. This corresponds to a loss in binding free 
energy of 1.3 ± 0.1 kcal/mol for the F303L mutation, a rather large change for a conservative 
replacement in a side chain that does not form direct contacts with the DNA. We interpret that a 
leucine at position 303 of E2C locks the 300-307 sequence in a conformation less favorable for 
binding than a phenylalanine. Altogether, our data confirm that the residue at position 303 is 
important for allowing the flexible C-terminal region of the E2C DNA binding helix to adopt a 
conformation that is capable of binding DNA, at the expense of protein stability.  
Binding of α1-E2C to a specific E2C DNA site  
We tested whether α1-E2C can bind DNA in a tight and specific manner in the absence of the 
rest of the domain. Since the full-length domain targets a pseudopalindromic sequence using 
symmetrical helices, we tested binding of α1-E2C to a target half-site, hemisite35 (see methods). 
Preliminary fluorescence spectroscopy experiments indicated that the affinity of α1-E2C for 
hemisite35 is too low to be measured using fluorescein-labeled DNA unlike full-length E2C 
16
. 
Moreover, there is no tryptophan residue in the peptide to follow the inverse titration in excess of 
unlabeled DNA 
16
. We carried out electrophoretic mobility shift assays (EMSA) at 25 °C in 10 
 12 
mM phosphate, pH 7.0 to obtain an estimate for the affinity of α1-E2C towards DNA (Figure 7) 
(see materials and methods). The free DNA and the peptide-DNA complexes migrated in 
opposite directions due to the high isoelectric point of α1-E2C (~11) (data not shown). The 
fluorescence corresponding to the free DNA was used to estimate the dissociation constant (KD). 
α1-E2C binds fluorescein-labeled hemisite35 with a KD of ~7 µM (Figure 7A). The same KD was 
obtained in the experiments performed with fixed concentrations of DNA and peptide (Figure 
7A). Our results are in reasonable agreement with the KD of ~1 µM measured for a similar 
peptide in different buffer conditions 
53
. The dissociation constant for the complex between α1-
E2C and a randomized oligonucleotide, iset-35, is approximately 50 µM (Figure 7A). Thus, α1-
E2C shows a small degree of sequence specificity, binding its target DNA about 7-fold stronger 
than a nonspecific sequence. Full-length E2C binds the same DNA much more strongly (KD in 
the low nanomolar range 
16,18,20
) and with more than 1000-fold specificity 
16,18
. 
α1-E2C shows nascent native helical structure in solution, strongly resembling the conformation 
of the same sequence within the full-length E2C domain, both free and in complex with DNA 
(Figure 4) 
13,14
. We have used CD spectroscopy to test whether the peptide folds into a helical 
conformation upon specific DNA binding. We co-incubated α1-E2C and hemisite35 at 25 °C in 
10 mM phosphate, pH 7.0. The concentration of both species was 25 µM, enough for binding 
saturation according to the estimated KD of ~7 µM. An analogous experiment using full-length 
E2C was able to detect binding-induced changes in the DNA 
16
. Figure 7B shows that in both the 
far-UV and the near-UV regions the sum of the individual spectra was indistinguishable from the 
spectrum of the mixture. Thus, formation of the complex between α1-E2C and DNA does not 
induce alpha helix formation in α1-E2C and does not induce conformational changes in the 
DNA. The lack of structural stabilization by binding agrees with the low affinity non-specific 
binding we observe. 
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Discussion 
The re-definition of the DNA binding helix of the HPV16 E2C domain in solution as a strained 
helix, with a bona fide α-helix at its N-terminal half, and a distorted C-terminal half containing 
310 helix, finds a remarkable correlation with our results for the α1-E2C peptide (Figure 1, 
bottom). Overall, the peptide shows a significant tendency to adopt a helical conformation since 
a long and stable α-helix starting from residue A292 to H306 is clearly formed in TFE. At high 
concentrations of urea, there is an increase in PPII elongated conformations in the C-terminal 
end of the peptide. In the absence of TFE or urea we found evidence for the incipient formation 
of both α-helix (A292-C298) and PPII conformations (L299-K305). The large number of 
positively charged residues present in the second half of the peptide appears as a logical 
explanation for the formation of an extended PPII conformer.  
The particular dimeric β-barrel topology of E2C holds the DNA binding helix in a “ready for 
binding” conformation 
10,13,14,17,21
. In line with this, the F303L substitution shows that anchoring 
the C-terminal half of the DNA binding helix to the outer face of the β-barrel not only modulates 
the stability of the protein, but also affinity for DNA as much as mutation of many residues 
contacting the DNA (Figure 6) 
20
. This “ready for binding” conformation is strained and 
malleable. Molecular dynamics simulations suggested that the C-terminal region of the DNA 
binding helix spends a significant amount of time in a polyproline type II conformation 
26,27
, and 
the two monomers in the crystal structure of HPV18 E2C differ mostly in the conformation of 
this part, leading to a different structural alignment for monomer A (Figure 1). The tertiary 
structure of this region heavily stabilizes the neutral form of H306, leading to a diminished pKa 
value with respect to a solvent-exposed histidine. Upon protonation of H306, several amide 
groups of residues in this region show chemical shift perturbation. Although we cannot exclude 
that this behaviour is simply the consequence of being close to the histidine ring that changes 
protonation state, it is conceivable that a protonated histidine will cause a conformational 
transition in view of the altered pKa and tautomer populations observed for H306 at 
physiological pH. Although further experiments will be necessary to understand how the domain 
stabilizes a 310 helix in this region, we have now established experimentally that the helix to 
polyproline II transition is caused by the conformational preferences of this sequence stretch and 
that these are of local nature (Figures 4 and 5). It has been suggested that polyproline type II 
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conformations can act as nucleation sites for the formation of oligomeric β-sheet structure 54,55. 
Since the DNA binding helix unfolds in the initial step of the E2C amyloid route 
33
, we propose 
that nascent PII structure in its C-terminal region may act as a nucleation site for the amyloid 
route of the domain. 
NMR measurements in mild denaturing conditions identified residual structure in the unfolded 
state of E2C in the regions corresponding to the DNA binding helix and the β2 strand in the 
native state of the domain 
30
. The residual structure consists mainly of α-helix in residues 292-
297 and of beta sheet and turns in residues 300-304 
30
, in good agreement with the nascent 
secondary structure of α1-E2C (Figure 1). This result shows that residual structure in the E2C 
DNA binding helix in the unfolded state is of local nature and is independent of residual 
structure in the adjacent β2-strand. The coincidence between the residual structure in the 
unfolded state and the regions of α and 310 helix in the folded domain is remarkable and 
underlines the importance of the local conformational tendencies of this sequence during folding 
of the entire domain. 
Short natural sequences from intrinsically disordered domains 
6,7
, or proteins with few long-
range contacts 
8,9
 have high intrinsic helix propensity and are able to fold into α-helices upon 
binding of their cognate DNA 
3-5
. Despite having high intrinsic helix propensity, binding of the 
α1-E2C peptide to hemisite35 is extremely weak and does not induce formation of alpha helix or 
any other observable structure (Figure 7). Interestingly, non-cognate peptide-nucleic acid 
interactions from in vitro selection adopt from structured helices to disordered but foldable 
structures upon binding 
56
. These results suggest that evolution finely tunes the conformational 
preferences of DNA binding helices beyond solely helical propensity to ensure tight and specific 
DNA binding and regulatory functions modulated by conformational switches. This tuning may 
be exerted through local interactions 
6-9
 or, as for α1-E2C, in the context of this particular 
dimeric β-barrel domain. The case of E2 shows a strained “non-canonical” DNA binding helix, 
highly conserved among all known papillomaviruses, that contains two of the three folding 
nuclei 
30
, indicating an evolution driven strong interplay between DNA recognition, folding 
initiation and conformational modulation. Perhaps these traits are reflected in the unusually high 
 15 
global dynamic nature yet highly stable characteristics of this domain, with a strong coupling 




Materials and methods 
Peptide Synthesis and Purification. The α1-E2C peptide contains residues 289-307 of HPV16 E2 
(LKGDANTLKCLRYRFKKHA). The last residue in the sequence was mutated from Cys to Ala 
to avoid redox side reactions. The peptide was synthesized at the Yale University Keck facility, 
with N-terminus acetylated and C-terminus amidated, and purified by reverse phase HPLC. We 
confirmed its molecular mass by mass spectrometry. Quantification of peptide concentration was 
carried out by absorbance at 274 nm and 220 nm.  
DNA Synthesis. Fluorescein-labeled single-stranded oligonucleotides containing the complete 
target site 35 of the HPV16 genome (5’ GTAACCGAAATCGGTTGA 3’), a hemisite (5’ 
GTAGCACAAATCGGTTGA 3’) and a randomized site (5’ ACATGGACCTGTCAAAGTA 3’) 
were purchased, HPLC purified, from Integrated DNA technologies (Coralville, IA). Double-
stranded oligonucleotides were annealed by mixing equal amounts of each strand in 10 mM Bis-
Tris-HCl buffer, pH 7 and 50 mM NaCl, incubating 5 minutes at 95 °C, and slowly cooling to 25 
°C for 16 hours. Completeness was checked by native polyacrylamide gel electrophoresis. 
Circular Dichroism. CD measurements were carried out on a Jasco J-810 spectropolarimeter 
using a Peltier temperature-controlled sample holder and a 0.1 cm path length cell. The measured 
molar ellipticity of a peptide containing α-helix, polyproline type II (PII) and coil conformations 





θ[ ]= fα θ[ ]α + fPII θ[ ]PII + fU θ[ ]U     [1] 
where   f i are the fractions of each conformation and   
θ[ ]
i
 the mean residue ellipticities of these 
conformations. The relationship between the number of residues in α-helical conformation and 














      [2] 
There are not established values for [θ]PII and [θ]U.  
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We used increasing amounts of 1,1,1-trifluoroethanol (TFE) and guanidinium chloride (GdmCl) 
to stabilize α-helix and PII conformations, respectively 40-42. If we assume that the populations of 
PII (for the TFE titration) and α-helix (for the GdmCl titration) do not change significantly 
during the titration, we can fit the observed ellipticity to a two-state equilibrium model 
39,58
. 
  Coil ↔α − helix;Coil ↔ PII     [3] 
We considered the free energy for α-helix formation to depend linearly on the TFE/water molar 
ratio and the PII structures to depend on the molar concentration of GdmCl, with a 
proportionality constant m: 
  
∆Gcoil↔α−helix([ TFE ] /[ water ])= ∆Gcoil↔α−helix
0%TFE − mTFE ⋅ [TFE ] /[ water ];
∆Gcoil↔PII ([GdmCl ])= ∆Gcoil↔PII
0MGdmCl − mPII ⋅ [GdmCl ]
  [4] 
The molar ellipticity at a fixed wavelength (222 nm for α-helix, 218 nm for PII) during the 
titration can be fitted to the following equation to extract values for DG and m: 
  
θ[ ]=
θ[ ]TFE ,GdmCl + θ[ ]water ⋅ exp −∆G TFE,GdmCl( ) RT( )
1+ exp −∆G TFE,GdmCl( ) RT( )
   [5] 
where [θ]water and [θ]TFE,GdmCl are the mean residue ellipticities in water and at high cosolvent 
concentration, R is the gas constant and T is the temperature. 
NMR Experiments. α1-E2C (3 mM) was dissolved in aqueous buffer (20 mM phosphate buffer 
pH 6.5, 2 mM DTT, 0.01% NaN3 and 5% D2O), TFE/water mixture (40% TFE-d3, 60% 20 mM 
phosphate pH 6.5, 2 mM DTT and 0.01% NaN3) and urea/water mixture (8M urea, 20 mM 
phosphate pH 6.5, 2 mM DTT, 0.01% NaN3 and 5% D2O). We used urea instead of GdmCl for 
NMR experiments because it was not possible to tune the probe in presence of high 
concentrations of GdmCl. The NMR experiments were performed at 25 °C or 5 °C using a 
Bruker Avance 700 and Avance 400 spectrometers equipped with triple resonance probes 
incorporating self-shielded gradient coils. All the heteronuclear correlation experiments were 
carried out at natural abundance. Pulsed field gradients were appropriately employed to achieve 
suppression of the solvent signal and spectral artifacts. Quadrature detection in the indirectly 
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detected dimensions was obtained using the States-TPPI method 
59
 or the echo-antiecho method. 
The spectra were processed on Silicon Graphics workstations by the NMRPipe software 
60
 and 
analyzed using NMR View 
61
. Assignment of backbone resonances of α1-E2C was performed 















C] HMQC-TOCSY (mixing times of 40 and 
80 ms) 
64
, the latter mentioned being very helpful due to the overlap of the signals. The 
sequential connectivity across the peptide was established using the NOESY and ROESY spectra 
(mixing times of 0.15 s and 0.20 s) 
65




JCαHα coupling constants were measured from the in-phase splitting patterns of the Cα-Hα cross-
peaks in the HMQC spectra without carbon decoupling. The 
3
JHNHα values were measured from 




C] HSQC-TOCSY spectrum 
collected with 8k complex data points in F2. 
Uniformly 
15
N-labeled HPV-16 E2 DNA-binding domain was expressed and purified as 
previously described 
31
. The protein concentration was 0.4 mM in 50 mM sodium phosphate, 5 
mM DTT, pH 6.5. NMR experiments of protein samples were performed at 30 °C on a Bruker 




N HSQC spectra were recorded at distinct pH 
values, namely pH 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0. At pH higher than 9.0 and lower than 
5.0, irreversible protein precipitation occurred. A total of 4096 complex points in t2 with 256 t1 
increments were acquired. The spectral widths were set to 6410 Hz in F2 and 1120 Hz in F1, 





N long range HSQC (LR-HSQC) spectrum was acquired to observe two-bond 
correlations between nitrogen and proton resonances belonging the histidine side-chain spin 
system 
67
. The delay for the INEPT-type magnetization transfer in the LR-HSQC was set to 11 
ms. A total of 2048 complex points in t2 with 64 t1 increments were acquired. Spectral width was 
6410 Hz in F2 and 4258 Hz in F1, placing the carrier frequency at 4.70 ppm in the proton 
dimension and at 208.4 ppm in the nitrogen dimension. 
The pKa values of titration curves were determined by analyzing the pH dependencies of amide 
N and H
N 









resonances in the LR-HSQC spectra for histidine side chains. The pH titration curves were fitted 




δpr +  δnonpr ⋅10( pH − pKa)
1+10( pH − pKa)
    [6] 
in which δobs is the chemical shift observed at each pH value and δpr and δnonpr are the chemical 
shifts for the protonated and deprotonated histidines, respectively. Curve fits were performed 
using the KaleidaGraph3.5 Software (Synergy Software). 
E2C mutant F303L. Site-directed mutagenesis, recombinant expression and purification were 
performed as described 
16,20
. Equilibrium binding to the full target DNA site35 was followed by 
fluorescence spectroscopy in 20 mM bis-Tris/HCl pH 7.0, 0.2 M NaCl, 1 mM DTT, at 25 °C. A 




Irreversible thermal denaturation was followed by the change in molar ellipticity at 225 nm in 20 
mM bis-Tris/HCl pH 7.0, 0.2 M NaCl, 1 mM DTT, 1 M GdmCl, scanning at 2 K/min. The data 
were fitted to a one-step irreversible denaturation model for a transition between a native dimer 




θ[ ]= exp −exp



























+ 1− exp −exp



































  [7] 
Where [θ]N and [θ]U are the molar ellipticities of the native and irreversibly denatured states, R is 
the gas constant, T is temperature, Tm is the temperature at which the protein is 50% denatured 
and EA is the activation enthalpy at Tm. 
Electrophoretic Mobility Shift Assay (EMSA). Reaction mixtures contained 1 µM fluorescein-
labeled hemisite35 (or fluorescein-labeled randomized site) and different amounts of α1-E2C or 
10µM α1-E2C and increasing amounts of fluorescein-labeled hemisite35. Mixtures were 
incubated 60 min at room temperature in a final volume of 10 µL in 10 mM phosphate pH 7.0, 1 
mM DTT. Mixtures were loaded continuously into running non-denaturing 10% polyacrylamide 
gels containing TBE 0.5x (0.1 M Tris-HCl pH 8.0 0.15 M sodium borate, 4 mM EDTA). The 
gels were resolved at 4 V/cm, 10 °C for 2 h. Fluorescein bands corresponding to free 
oligonucleotide were detected by UV and used to extract the dissociation constant as described 
 20 
16,20
. We used a gel with increasing concentrations of fluorescein-labeled site without peptide to 




This work was supported by Welcome Trust [GR077355AYA]; Agencia Nacional de Promoción 
Científica y Tecnológica [PICT 2000 01-08959]; Consejo Nacional de Investigaciones 
Científicas y Técnicas [doctoral fellowship to A.D.N. and D.U.F., G.P.G. and D.W. are Career 
Investigators]; and Agencia Española de Cooperación Internacional [postdoctoral fellowship to 
I.E.S.]. We would like to acknowledge Mariano Dellarole for discussion. 
 22 
Figure legends 








 and HPV16 
13,14
, in the unfolded state of HPV16 E2C 
30
 and in 
the α1-E2C peptide under different conditions (this work). β-strands are shown as arrows, α-
helices as red cylinders, 310 helices as green rectangles and folding nuclei as blue cylinders. 
Numbering corresponds to HPV16 E2C. The first residues in the HPV18 E2C structure are HM 
due to the cloning procedure, but NT in nature. The two monomers of this domain present 
slightly different structures in the crystal and are shown separately. 
Figure 2. Structural characterization of α1-E2C by far-UV circular dichroism. Buffer is 10 mM 
sodium phosphate, pH 7.0 and peptide concentration is 40 µM, temperature is 25 °C unless 
stated otherwise. (A) Spectra of α1-E2C from 5 to 85 °C. Also shown is the spectrum of full-
length E2C for comparison (dashed line). Inset: Difference spectrum between 5 and 85 °C. (B) 
Spectra of α1-E2C at 5 °C from 0 to 6M GdmCl. Inset: Molar ellipticity at 218 nm as a function 
of GdmCl concentration and fit to a two-state coil-PII equilibrium (3). (C) Spectra of α1-E2C in 
10 mM sodium citrate-phosphate buffer at pH from 3.4 to 8.4. Inset: Molar ellipticity at 200 nm 
as a function of pH. (D) Spectra of α1-E2C from 0 to 60% (v/v) TFE. Inset: Molar ellipticity at 
222 nm as a function of TFE concentration and fit to a two-state coil-helix equilibrium.  
Figure 3. [13C,1H]-HSQC NMR spectra of α1-E2C in aqueous buffer (blue), 40% TFE (black) 
and 8M urea (red). All experiments were performed in 20 mM phosphate, pH 6.5 at 25 °C and 
natural isotope abundance.  






Cβ for α1-E2C in 40% TFE, in aqueous buffer and in 8 M urea in the top, middle 
and lower panels, respectively. The chemical shift indexes were calculated using NMRView 
44
. 
Index values depicted as downward blue arrows are indicative of β-strands, upward red arrows 
of α-helices, and gray bars are used for 0 index values. (B) 1JCαHα coupling constants relative to a 
random coil conformation 
56
. The value of 1.1 Hz is signaled in the plot. Black triangles: TFE 








Cβ, and CO for the DNA recognition helix in the full-length E2C (
44
, 
BioMagResBank database accession number 5952). 
Figure 5. Effect of pH on the E2C DNA binding helix. (A) Titration of H306, followed by 1H 
chemical shift. The line is a fit to a modified Henderson-Hasselbalch equation (see methods). (B) 
Titration of F303, followed by 
15
N chemical shift. The line is a fit to a modified Henderson-
Hasselbalch equation (see methods). (C) Residues affected by titration of H306. The observed 
pKa-values for these residues range from 5.4 to 5.8. 
Figure 6. Mutation of hinge residue F303 of E2C to leucine. (A) Stability of wild type (empty 
circles) and F303L (black circles) E2C against irreversible thermal denaturation, followed by CD 
at 225 nm. The line is a fit to a one-step irreversible denaturation model for a transition between 
a native dimer and an irreversibly denatured monomer 
51,52
 (see materials and methods). (B) 
Binding of F303L E2C to fluorescein-labeled specific target site35, followed by fluorescence. 
The line is a fit to a quadratic binding equation 
20
 (see materials and methods). 
Figure 7. DNA binding by α1-E2C. (A) Electrophoretic Mobility Shift Assay. Top panels show 
the polyacrylamide gel and bottom panels the complex concentration as a function of α1-E2C or 
DNA. All lines are fits to a quadratic binding equation 
20
. Reaction mixtures in the left panels 
contain 1 µM fluorescein-labeled hemisite35 (filled circles) or randomized iset35 (empty circles) 
and increasing amounts of α1-E2C. Reaction mixtures in the right panels contain increasing 
amounts of fluorescein-labeled hemisite35 and no peptide or 10µM α1-E2C (filled circles). The 
lanes in the absence of peptide show that the fluorescence signal is proportional to the 
concentration of DNA. (B) CD spectra of a stoichiometric (25  µM) mixture of α1-E2C and 
hemisite35 in 10 mM phosphate buffer, pH 7.0 (circles) and sum of spectra for the DNA and the 
peptide (triangles). The bottom panel shows the difference between the spectrum of the mixture 
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